Background and Purpose: The prevalence of a patent foramen ovale has been shown to be increased in patients with ischemic stroke. Transesophageal echocardiography, transthoracic echocardiography, and transcranial Doppler examination with contrast injection can all be used to search for a patent foramen ovale. We compared the accuracy of these techniques for identifying a patent foramen ovale in 49 patients with acute ischemic stroke or transient ischemic attack.
P aradoxical embolization through a patent foramen ovale is a well-recognized mechanism for embolic stroke,'-3 although its relative importance has not been established. The prevalence of patent foramen ovale has been shown to be higher in stroke patients than in control subjects,4,5 especially in cases of unexplained or cryptogenic infarctions.46 Contrast transthoracic echocardiography has been used to detect the presence of a patent foramen ovale.7-9 Recently, transesophageal echocardiography with contrast injection has been shown to be more sensitive than transthoracic echocardiography, and it is currently considered the "gold standard" to establish the presence of a patent foramen ovale.10 Transesophageal echocardiography, however, is a semi-invasive technique and may be difficult to perform in stroke patients with swallowing dysfunction. Transcranial Doppler examination of the middle cerebral artery during contrast injection has been recently proposed as an alternative method for the detection of right-to-left shunts.1"'12 The aim of the present study was to compare the accuracy of echocardiographic and transcranial Doppler techniques in detecting a patent foramen ovale in patients with stroke.
Subjects and Methods Forty-six patients with completed acute ischemic stroke and 5 patients with transient ischemic attack consecutively undergoing transesophageal echocardiography were entered in the study. Reasons for performing transesophageal echocardiography included the lack of a plausible cause for the cerebrovascular ischemic episode (cryptogenic stroke) or the suspicion of a possible embolic mechanism with no cardiac source identified on transthoracic echocardiography. Esopha-geal intubation was not successful in 2 patients (4%). Therefore, the study population consisted of 4-9 patients (27 men, 22 The right middle cerebral artery was insonated and the apical four-chamber view was imaged during contrast injection (transthoracic study). The basilar artery was insonated in two patients because of the inability to insonate the middle cerebral artery. The middle cerebral artery was insonated through the temporal window at a depth of 50 to 55 mm; the basilar artery was insonated from the suboccipital window at a depth of 80 to 85 mm. The same protocol was followed during four-chamber view imaging in the transverse plane for the transesophageal study. Contrast material was prepared by mixing 10 mL of saline with 0.5 to 1.0 mL of air by means of two syringes mounted on a three-way stopcock. The suspension contained air microbubbles ranging from 30 to 110 gm in diameter (direct microscopy measurement).
During the test, the suspension was rapidly injected into an antecubital vein. A patent foramen ovale was considered to be present when at least one microbubble was seen in the left atrium within three cardiac cycles from their appearance in the left atrium (transthoracic and transesophageal echocardiography; Fig 1) or when typical spikes were insonated on the baseline cerebral artery tracing (transcranial Doppler; Fig 2) , along with a characteristic acoustic signal. The tests were repeated during Valsalva maneuver to increase their sensitivity.5,9
The studies were then independently interpreted by two experienced readers, each one blinded to the results of the other studies. Sensitivity and specificity for the detection of a patent foramen ovale by transcranial Doppler and transthoracic echocardiography were calculated using transesophageal echocardiography as the gold standard. Sensitivity was then recalculated stratified by infarct subtype. Differences between proportions were tested using x2 or Fisher's Exact Test (two-tailed).
Results
Contrast transesophageal echocardiography detected a patent foramen ovale in 19 of the 49 patients (39%). Actual determination of the foramen size (defined as the separation between septum primum and septum secundum in longitudinal view) was possible in 11 of them (58%) and ranged from 1 to 4 mm. Two patients also had an atrial septal aneurysm (defined as a localized outpouching of the fossa ovalis region with base width of 1.5 cm or more and excursion into either the left or the right atrium or both of 1.1 cm or more14). In 4 patients the study was positive only during Valsalva maneuver. Two patients had evidence of intrapulmonary shunt, suggested by the late appearance of microbubbles into the left atrium and confirmed by their direct visualization in the pulmonary veins (Fig 3) . One of these 2 patients also had evidence of a patent was therefore 47%, and its specificity 100% (Table) . Inadequate image quality accounted for 6 of the 10 false-negative cases; had these 6 patients been excluded from the analysis, the sensitivity of transthoracic echocardiography would have risen to 69% (9/13 patients). The sensitivity of transthoracic echocardiography was slightly greater in patients aged younger than 55 years (3/5; 60%) than in older patients (6/14; 43%), probably due to the better image quality achievable in younger individuals. Transthoracic echocardiography failed to identify any of the patients with intrapulmonary shunt and only identified 1 patient (2%) with another potential cardiac embolic source (mitral annular calcification).
Although statistical significance was not reached, the prevalence of patent foramen ovale by transesophageal echocardiography was greater in patients with cryptogenic stroke (9/19; 47%) than in patients with stroke of determined origin (8/25; 32%). Two of the 5 patients with transient ischemic attack (40%) also had a patent foramen ovale. The size of the foramen was slightly greater in cryptogenic stroke patients than in patients with stroke of determined origin (2.0±3.8 mm versus 0.9±1.1 mm). The sensitivity for patent foramen ovale detection of transthoracic echocardiography was slightly greater in patients with cryptogenic stroke (6/9 patients; 67%) than in patients with stroke of determined origin (2/8 patients; 25%; Table) , but the small sample size limited the statistical significance. A similar trend was observed for transcranial Doppler (7/9 patients, or 78%, in cryptogenic stroke patients versus 4/8 patients, or 50%, in patients with stroke of determined origin; Table) .
Discussion
The association between patent foramen ovale and stroke has recently been demonstrated by several studies. Lechat The search for a patent foramen ovale in patients with ischemic stroke requires diagnostic tests that are sensitive, specific, widely available, and easy to perform even in acutely ill patients. Transesophageal echocardiography is considered the most sensitive noninvasive technique for detecting a patent foramen ovale.10,5-'7 In our series transesophageal echocardiography led to the detection of the greatest number of patients with a patent foramen ovale and was considered to be the gold standard for this diagnosis. Transesophageal echocardiography also detected other cardiac abnormalities in 14% of our patients. Therefore, the overall yield of transesophageal echo for a potential cardiac source of emboli approached 50% in our study, confirming its diagnostic usefulness.10'5-17 Esophageal intubation was not successful in only two patients, and no complications were observed during or after the test. Transesophageal echocardiography, therefore, can be safely performed in the majority of patients with acute stroke.
Transcranial Doppler examination detected a patent foramen ovale in 68% of patients identified by transesophageal echocardiography. In a recent study, Nemec et al18 observed that transcranial Doppler had 100% sensitivity for patent foramen ovale, but only 50% for intrapulmonary shunt. The latter was defined by the late appearance of microbubbles in the left atrium during transesophageal echocardiography; no attempt was reported to directly visualize the microbubbles in the pulmonary veins. If one combines the figures for patent foramen ovale and intrapulmonary shunt, the overall sensitivity of transcranial Doppler for right-to-left shunt drops to 84% in that study and to 68% in ours. In another recent study, Karnik et al19 reported an 87% sensitivity of transcranial Doppler for patent foramen ovale detection, without addressing the issue of intrapulmonary shunts. Overall, transcranial Doppler examination appears to be very sensitive in detecting large or moderate shunts, but less sensitive for smaller ones. These "microshunts" are characterized by a lower number, and possibly smaller size, of shunting microbubbles. Their clinical relevance, in terms of target organ involvement after paradoxical embolization, remains to be established.
Transthoracic echocardiography was the least sensitive technique for detecting a patent foramen ovale among those compared in our study. This 
